Marta Rubies Bedos
PhD student at Department of Immunology, Genetics and Pathology; Research programme: Cancer Immunotherapy; Research group Yumeng Mao
- E-mail:
- marta.rubies_bedos@igp.uu.se
- Visiting address:
- Dag Hammarskjölds väg 20
751 85 Uppsala - Postal address:
- Rudbecklaboratoriet
751 85 UPPSALA
Publications
Recent publications
Epigenetic regulation of cell state by H2AFY governs immunogenicity in high-risk neuroblastoma
Part of Journal of Clinical Investigation, 2024
- DOI for Epigenetic regulation of cell state by H2AFY governs immunogenicity in high-risk neuroblastoma
- Download full text (pdf) of Epigenetic regulation of cell state by H2AFY governs immunogenicity in high-risk neuroblastoma
Part of Nature Communications, 2024
- DOI for Loss of NEDD8 in cancer cells causes vulnerability to immune checkpoint blockade in triple-negative breast cancer
- Download full text (pdf) of Loss of NEDD8 in cancer cells causes vulnerability to immune checkpoint blockade in triple-negative breast cancer
Part of Journal of Clinical Investigation, 2023
- DOI for Interleukin-1 receptor-associated kinase-3 acts as an immune checkpoint in myeloid cells to limit cancer immunotherapy
- Download full text (pdf) of Interleukin-1 receptor-associated kinase-3 acts as an immune checkpoint in myeloid cells to limit cancer immunotherapy
All publications
Articles in journal
Epigenetic regulation of cell state by H2AFY governs immunogenicity in high-risk neuroblastoma
Part of Journal of Clinical Investigation, 2024
- DOI for Epigenetic regulation of cell state by H2AFY governs immunogenicity in high-risk neuroblastoma
- Download full text (pdf) of Epigenetic regulation of cell state by H2AFY governs immunogenicity in high-risk neuroblastoma
Part of Nature Communications, 2024
- DOI for Loss of NEDD8 in cancer cells causes vulnerability to immune checkpoint blockade in triple-negative breast cancer
- Download full text (pdf) of Loss of NEDD8 in cancer cells causes vulnerability to immune checkpoint blockade in triple-negative breast cancer
Part of Journal of Clinical Investigation, 2023
- DOI for Interleukin-1 receptor-associated kinase-3 acts as an immune checkpoint in myeloid cells to limit cancer immunotherapy
- Download full text (pdf) of Interleukin-1 receptor-associated kinase-3 acts as an immune checkpoint in myeloid cells to limit cancer immunotherapy